验证数据展示
经过测试的应用
| Positive IF/ICC detected in | HepG2 cells | 
推荐稀释比
| 应用 | 推荐稀释比 | 
|---|---|
| Immunofluorescence (IF)/ICC | IF/ICC : 1:50-1:500 | 
| It is recommended that this reagent should be titrated in each testing system to obtain optimal results. | |
| Sample-dependent, Check data in validation data gallery. | |
产品信息
CL594-67308 targets Alpha 2-Antiplasmin in IF/ICC applications and shows reactivity with Human samples.
| 经测试应用 | IF/ICC Application Description | 
| 经测试反应性 | Human | 
| 免疫原 | 
                                             CatNo: Ag4095 Product name: Recombinant human SERPINF2 protein Source: e coli.-derived, PGEX-4T Tag: GST Domain: 146-491 aa of BC031592 Sequence: HLLSRLCQDLGPGAFRLAARMYLQKGFPIKEDFLEQSEQLFGAKPVSLTGKQEDDLANINQWVKEATEGKIQEFLSGLPEDTVLLLLNAIHFQGFWRNKFDPSLTQRDSFHLDEQFTVPVEMMQARTYPLRWFLLEQPEIQVAHFPFKNNMSFVVLVPTHFEWNVSQVLANLSWDTLHPPLVWERPTKVRLPKLYLKHQMDLVATLSQLGLQELFQAPDLRGISEQSLVVSGVQHQSTLELSEVGVEAAAATSIAMSRMSLSSFSVNRPFLFFIFEDTTGLPLFVGSVRNPNPSAPRELKEQQDSPGNKDFLQSLKGFPRGDKLFGPDLKLVPPMEEDYPQFGSPK 种属同源性预测 | 
                                    
| 宿主/亚型 | Mouse / IgG1 | 
| 抗体类别 | Monoclonal | 
| 产品类型 | Antibody | 
| 全称 | serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2 | 
| 别名 | A2AP, AAP, Alpha 2 antiplasmin, Alpha 2 AP, ALPHA 2 PI, Alpha 2 plasmin inhibitor, API, PLI, Serpin F2, SERPINF2 | 
| 计算分子量 | 491 aa, 55 kDa | 
| GenBank蛋白编号 | BC031592 | 
| 基因名称 | Alpha-2-antiplasmin | 
| Gene ID (NCBI) | 5345 | 
| RRID | AB_2920109 | 
| 偶联类型 | CoraLite®594 Fluorescent Dye | 
| 最大激发/发射波长 | 588 nm / 604 nm | 
| 形式 | Liquid | 
| 纯化方式 | Protein G purification | 
| UNIPROT ID | P08697 | 
| 储存缓冲液 | PBS with 50% glycerol, 0.05% Proclin300, 0.5% BSA, pH 7.3. | 
| 储存条件 | Store at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage. | 
实验方案
| Product Specific Protocols | |
|---|---|
| IF protocol for CL594 Alpha 2-Antiplasmin antibody CL594-67308 | Download protocol | 
| Standard Protocols | |
|---|---|
| Click here to view our Standard Protocols | 
